Personal stories

Health workers and first responders bear a double burden as survivors themselves, dealing with their own losses while helping their communities recover and rebuild in the aftermath of a disaster.

SwipeRx is equipping pharmacies in Southeast Asia to advance patient care and transform global health. J&J Impact Ventures, an investment fund within the J&J Foundation, provided SwipeRx tailored pro bono services from J&J employees, which has proven instrumental in shaping the company’s future.

Eleven high school students from New Jersey—each representing a different congressional district—traveled to Washington, D.C., earlier this year to participate in the Close Up Foundation’s Washington, D.C. civic engagement program as Johnson & Johnson Scholars.

A Johnson & Johnson scientist explains how the new Acuvue® Oasys Max 1-Day Multifocal for Astigmatism contact lens also filters blue light, supports the eye’s natural tear film and helps eyes easily switch focus from distance to reading.

In 2023, J&J Impact Ventures, an investment fund within J&J Foundation, invested in Penda Health to support and expand access to trustworthy, high-quality healthcare to communities in Kenya. Impact Ventures’ essential support included providing Penda Health with pro bono services from Johnson & Johnson employees with expertise and insights.

Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and a potential targeted treatment developed by Johnson & Johnson that’s currently in clinical trials.

Behind every innovative medicine, treatment and therapy is a clinical trial. To help you understand them better, here’s a closer look at how they work.

Jennifer Huff and Jacqui Mellott are two of Johnson & Johnson’s oncology clinical educators—a team of 50 nurses who visit hospitals and infusion centers to help providers understand and stay up to date with treatments.

What 500 oncology professionals say about the current state of cancer care